Alerts will be sent to your verified email
Verify EmailSAROJA
Saroja Pharma Ind
|
Hamps Bio
|
Chemo Pharma Labs
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
33.33 % | 14.19 % | -4.51 % |
5yr average Equity Multiplier
|
4.66 | 2.36 | 1.01 |
5yr Average Asset Turnover Ratio
|
2.98 | 1.18 | 0.0 |
5yr Avg Net Profit Margin
|
2.08 % | 5.23 % | 0.0 |
Price to Book
|
0.0 | 2.05 | 1.37 |
P/E
|
17.48 | 59.55 | 0.0 |
5yr Avg Cash Conversion Cycle
|
80.28 Days | 74.76 Days | 0.0 |
Inventory Days
|
11.27 Days | 53.3 Days | 0.0 |
Days Receivable
|
122.72 Days | 59.7 Days | 0.0 |
Days Payable
|
47.62 Days | 80.45 Days | 0.0 |
5yr Average Interest Coverage Ratio
|
2.76 | 3.45 | 794.39 |
5yr Avg ROCE
|
37.65 % | 18.02 % | -3.17 % |
5yr Avg Operating Profit Margin
|
4.76 % | 14.19 % | 0.0 |
5 yr average Debt to Equity
|
1.78 | 0.99 | 0.01 |
5yr CAGR Net Profit
|
3.81 % | 20.11 % | n/a |
5yr Average Return on Assets
|
6.13 % | 6.19 % | -4.13 % |
Shareholdings
|
|||
Promoter Holding
|
73.02 % | 71.99 % | 27.89 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Saroja Pharma Ind
|
Hamps Bio
|
Chemo Pharma Labs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|